Valuation GlaxoSmithKline plc LIQUIDNET SYSTEMS

Stocks

Delayed LIQUIDNET SYSTEMS Other stock markets			5-day change	1st Jan Change
- ^EUR	-.--%		-0.40%	-

19/06	Moderna Secures Favorable FDA Panel Recommendation for mRNA Flu Vaccine
18/06	The Gulf Gives, the Fed Takes

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	80,458	58,381	59,112	54,944	73,201	76,765	-	-
Change	-	-27.44%	1.25%	-7.05%	33.23%	4.87%	-	-
Enterprise Value (EV) ¹	100,296	75,578	74,152	68,039	87,654	91,017	87,954	85,609
Change	-	-24.65%	-1.89%	-8.24%	28.83%	3.84%	-3.37%	-2.67%
P/E	18.6x	3.93x	11.9x	21.3x	12.9x	12.3x	11.4x	11.1x
PBR	5.34x	5.47x	4.4x	4.02x	-	4.56x	3.76x	3.19x
PEG	-	0x	-0.2x	-0.4x	0x	1.2x	1.43x	4.29x
Capitalization / Revenue	2.36x	1.99x	1.95x	1.75x	2.24x	2.27x	2.16x	2.1x
EV / Revenue	2.94x	2.58x	2.45x	2.17x	2.68x	2.69x	2.48x	2.34x
EV / EBITDA	8.85x	7.23x	6.37x	6.36x	7.77x	7.93x	7.16x	6.84x
EV / EBIT	11.4x	9.27x	8.44x	7.44x	8.96x	8.94x	8.02x	7.49x
EV / FCF	22.6x	12.1x	13.6x	13x	13.7x	16.3x	14.6x	13.6x
FCF Yield	4.42%	8.28%	7.36%	7.67%	7.32%	6.15%	6.86%	7.36%
Dividend per Share ²	1	0.6125	0.58	0.61	0.66	0.7006	0.7328	0.763
Rate of return	4.98%	4.26%	4%	4.53%	3.62%	3.64%	3.81%	3.97%
EPS ²	1.082	3.662	1.216	0.632	1.411	1.558	1.682	1.725
Distribution rate	92.4%	16.7%	47.7%	96.5%	46.8%	45%	43.6%	44.2%
Net sales ¹	34,114	29,324	30,328	31,376	32,667	33,783	35,477	36,579
EBITDA ¹	11,330	10,449	11,635	10,693	11,278	11,481	12,281	12,525
EBIT ¹	8,806	8,151	8,786	9,148	9,783	10,181	10,967	11,432
Net income ¹	4,385	14,956	4,928	2,575	5,716	6,266	6,669	6,902
Net Debt ¹	19,838	17,197	15,040	13,095	14,453	14,252	11,189	8,844
Reference price ²	20.08	14.38	14.50	13.46	18.24	19.23	19.23	19.23
Nbr of stocks (in thousands)	4,006,383	4,060,999	4,076,145	4,080,519	4,012,126	3,991,951	-	-
Announcement Date	9/2/22	1/2/23	31/1/24	5/2/25	4/2/26	-	-	-

¹GBP in Million²GBP

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
ELI LILLY AND COMPANY	32.54x	11.83x	24.36x	0.61%	992B
JOHNSON & JOHNSON	25.03x	5.77x	15.69x	2.28%	564B
ABBVIE INC.	27.45x	6.62x	13.53x	3.1%	391B
ROCHE HOLDING AG	17.47x	4.34x	10.68x	3.06%	330B
ASTRAZENECA PLC	22.62x	4.72x	13.39x	1.85%	280B
NOVARTIS AG	21.12x	5.46x	13.25x	2.94%	279B
NOVO NORDISK A/S	12.67x	4.72x	9.72x	3.98%	196B
AMGEN INC.	22.21x	5.97x	10.43x	2.95%	184B
GILEAD SCIENCES, INC.	-44.95x	5.42x	29.92x	2.59%	156B
Average	15.13x	6.10x	15.66x	2.59%	374.58B
Weighted average by Cap.	22.15x	7.33x	17.13x	2.13%